Steven R. Visuri
Directeur Général chez Stem Pharm, Inc.
Profil
Steven R.
Visuri was the founder of Floraseq LLC, founded in 2014, where he held the title of Chief Executive Officer.
Currently, he is the Chief Executive Officer at Stem Pharm, Inc. and an Advisor at Golden Angels Investors LLC.
In the past, he held the position of Senior Director at Hologic, Inc. from 2009 to 2014, and was the Chief Scientific Officer at Prodesse, Inc. from 2003 to 2010.
He also held the title of Senior Research Scientist & Group Leader at Lawrence Livermore National Laboratory.
Dr. Visuri received his graduate and doctorate degrees from Northwestern University and his undergraduate degree from Marquette University.
Postes actifs de Steven R. Visuri
| Sociétés | Poste | Début |
|---|---|---|
Stem Pharm, Inc.
 Stem Pharm, Inc. Medical DistributorsDistribution Services Stem Pharm, Inc. is a neurological drug discovery platform company that uses a human-first approach to develop the next-generation of neurologic drugs. The company is based in Madison, WI, a hub for innovative stem cell and biosciences research. The company's proprietary drug discovery platform is based on human 3D neuro-immune organoids that feature microglia and model neuroinflammation, which play a critical role in many neurological diseases. Stem Pharm applies this platform to discover and validate disease targets and therapeutics for its internal programs in epilepsy, neurodegeneration, and brain cancer as well as for its biopharma partners' therapeutic programs. The company was founded in 2015 by William L. Murphy, Connie Lebakken, and the CEO is Steven R. Visuri. | Directeur Général | - |
Golden Angels Investors LLC
 Golden Angels Investors LLC Investment ManagersFinance Golden Angels Investors LLC (Golden Angels Investors) is a venture capital firm founded in 2002 by Timothy J Keane. The firm is headquartered in Brookfield, Wisconsin. | Consultant / Advisor | 01/01/2013 |
Anciens postes connus de Steven R. Visuri
| Sociétés | Poste | Fin |
|---|---|---|
| HOLOGIC, INC. | Directeur/Membre du Conseil | 30/09/2014 |
Prodesse, Inc.
 Prodesse, Inc. Pharmaceuticals: MajorHealth Technology Prodesse, Inc. develops, manufactures, and distributes reagents for infectious disease agents. The company's products include Pro hMPV, for detection of human metapneumovirus; ProPneumo-1 that is for detection of mycoplasma pneumoniae and chlamydophila pneumoniae; ProPertussis, for detection of bordetella pertussis; ProGastro Cd for detection of toxigenic strains of clostridium difficile and Pro hMPV+, for detection of human metapneumovirus. It was founded in 1993 and is headquartered in Waukesha, WI | Directeur Technique/Scientifique/R&D | 28/09/2010 |
Floraseq LLC
 Floraseq LLC Miscellaneous Commercial ServicesCommercial Services Floraseq LLC develops microbiota-based products. It provides therapeutic and diagnostic solutions to treat gastrointestinal disorders. The company was founded by Steve Visuri and Karen Harrington and in 2014 and is headquartered in Waukesha, WI. | Directeur Général | - |
Lawrence Livermore National Laboratory
 Lawrence Livermore National Laboratory Miscellaneous Commercial ServicesCommercial Services Lawrence Livermore National Laboratory provides nuclear testing services. The Laboratory's security needs include countering the proliferation of weapons of mass destruction and strengthening homeland security against the terrorist use of such weapons. The company was founded in 1952 and is headquartered in Livermore, CA. | Corporate Officer/Principal | - |
Formation de Steven R. Visuri
| Northwestern University | Doctorate Degree |
| Marquette University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HOLOGIC, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Prodesse, Inc.
Prodesse, Inc. Pharmaceuticals: MajorHealth Technology Prodesse, Inc. develops, manufactures, and distributes reagents for infectious disease agents. The company's products include Pro hMPV, for detection of human metapneumovirus; ProPneumo-1 that is for detection of mycoplasma pneumoniae and chlamydophila pneumoniae; ProPertussis, for detection of bordetella pertussis; ProGastro Cd for detection of toxigenic strains of clostridium difficile and Pro hMPV+, for detection of human metapneumovirus. It was founded in 1993 and is headquartered in Waukesha, WI | Health Technology |
Lawrence Livermore National Laboratory
Lawrence Livermore National Laboratory Miscellaneous Commercial ServicesCommercial Services Lawrence Livermore National Laboratory provides nuclear testing services. The Laboratory's security needs include countering the proliferation of weapons of mass destruction and strengthening homeland security against the terrorist use of such weapons. The company was founded in 1952 and is headquartered in Livermore, CA. | Commercial Services |
Golden Angels Investors LLC
Golden Angels Investors LLC Investment ManagersFinance Golden Angels Investors LLC (Golden Angels Investors) is a venture capital firm founded in 2002 by Timothy J Keane. The firm is headquartered in Brookfield, Wisconsin. | Finance |
Floraseq LLC
Floraseq LLC Miscellaneous Commercial ServicesCommercial Services Floraseq LLC develops microbiota-based products. It provides therapeutic and diagnostic solutions to treat gastrointestinal disorders. The company was founded by Steve Visuri and Karen Harrington and in 2014 and is headquartered in Waukesha, WI. | Commercial Services |
Stem Pharm, Inc.
Stem Pharm, Inc. Medical DistributorsDistribution Services Stem Pharm, Inc. is a neurological drug discovery platform company that uses a human-first approach to develop the next-generation of neurologic drugs. The company is based in Madison, WI, a hub for innovative stem cell and biosciences research. The company's proprietary drug discovery platform is based on human 3D neuro-immune organoids that feature microglia and model neuroinflammation, which play a critical role in many neurological diseases. Stem Pharm applies this platform to discover and validate disease targets and therapeutics for its internal programs in epilepsy, neurodegeneration, and brain cancer as well as for its biopharma partners' therapeutic programs. The company was founded in 2015 by William L. Murphy, Connie Lebakken, and the CEO is Steven R. Visuri. | Distribution Services |
